How does PCRX's PB Ratio compare to its peers?

PCRX is expensive based on its Price-To-Book Ratio (2.5x) compared to the peer average (1.1x).

How does PCRX's PB Ratio compare vs other companies in the CA Consumer Retailing Industry?

PCRX is expensive based on its Price-To-Book Ratio (2.5x) compared to the North American Consumer Retailing industry average (2.3x).

What is PCRX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate PCRX's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of PCRX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate PCRX's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

PharmaCorp Rx (TSXV:PCRX) - Stock Price, News & Analysis

PCRX Stock Overview

Operates retail pharmacies under the PharmaChoice name in Canada. More details

PCRX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue (CA$1M)

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (CA$75M)

PharmaCorp Rx Inc. Competitors

CareRx

TSX:CRRX

CA$115.1m

Neighbourly Pharmacy

TSX:NBLY

CA$840.4m

Colabor Group

TSX:GCL

CA$102.0m

Ceres Global Ag

TSX:CRP

CA$99.5m

Price History & Performance

Summary of all time highs, changes and price drops for PharmaCorp Rx
Historical stock prices
Current Share Price	CA$0.64
52 Week High	CA$0.88
52 Week Low	CA$0.43
Beta	-6.35
11 Month Change	-8.57%
3 Month Change	-8.57%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	433.33%

Recent updates

Shareholder Returns

	PCRX	CA Consumer Retailing	CA Market
7D	0%	3.3%	0.8%
1Y	n/a	24.5%	22.3%

Return vs Industry: Insufficient data to determine how PCRX performed against the Canadian Consumer Retailing industry.

Return vs Market: Insufficient data to determine how PCRX performed against the Canadian Market.

Price Volatility

Is PCRX's price volatile compared to industry and market?
PCRX volatility
PCRX Average Weekly Movement	9.1%
Consumer Retailing Industry Average Movement	3.3%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.6%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: PCRX has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine PCRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Grady Brown	n/a

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; vitamins and supplements; and convenience and confectionary products. The company was incorporated in 2021 and is based in Saskatoon, Canada.

PharmaCorp Rx Inc. Fundamentals Summary

How do PharmaCorp Rx's earnings and revenue compare to its market cap?
PCRX fundamental statistics
Market cap	CA$75.04m
Earnings (TTM)	-CA$1.99m
Revenue (TTM)	CA$1.40m

53.8x

P/S Ratio

-37.7x

P/E Ratio

Is PCRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCRX income statement (TTM)
Revenue	CA$1.40m
Cost of Revenue	CA$881.75k
Gross Profit	CA$514.09k
Other Expenses	CA$2.50m
Earnings	-CA$1.99m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.017
Gross Margin	36.83%
Net Profit Margin	-142.45%
Debt/Equity Ratio	1.4%

How did PCRX perform over the long term?

See historical performance and comparison

PharmaCorp Rx TSXV:PCRX Stock Report